Rare diseases
Investigational molecules
Locations
Back to Italy2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors
ItalyStudy of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors
ItalyStudy of catequentinib (AL3818) combined with platinum chemotherapy for patients with recurrent or metastatic ovarian, fallopian tube, or primary peritoneal cancer
ItalyA Phase 2 Study to Evaluate Safety and Effectiveness of Omaveloxolone (RTA 408) in Patients with Friedreich's Ataxia
ItalyStudy on Bevacizumab and Erlotinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation
ItalyStudy on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma
ItalyStudy on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis
ItalyStudy of L19IL2 and L19TNF for Patients with Skin Cancer Suitable for Direct Tumor Injection
ItalyStudy on Carboplatin, Paclitaxel, Bevacizumab, and Rucaparib for Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Patients
ItalyStudy on Short-Course Radiotherapy and Chemotherapy with Fluorouracil, Irinotecan, and Oxaliplatin for Patients with Locally Advanced Rectal Cancer
ItalyStudy of Durvalumab and Tremelimumab for Patients with Resectable Liver Cancer
ItalyStudy of SBP-101, Nab-Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.
Multiple ongoing trials testing various therapeutic combinations to improve survival rates.
Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.
Focus on personalized treatment approaches and biomarker-driven therapies.
Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.
Studies aimed at improving long-term patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
